Science News
from research organizations

No benefit to aspirin for preserving cognitive function, review finds

Date:
April 20, 2017
Source:
Wiley
Summary:
An analysis of published studies found no evidence that low-dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.
Share:
FULL STORY

An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.

The review and meta-analysis included eight studies with 36,196 participants who were an average of 65 years old and did not have cognitive impairment at baseline. Participants were followed for an average of six years.

"Additional studies are needed to test the possibility that low-dose aspirin has beneficial effects when taken over a longer period and at an earlier age," said Dr. Nicola Veronese, lead author of the Journal of the American Geriatrics Society study.


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Nicola Veronese, Brendon Stubbs, Stefania Maggi, Trevor Thompson, Patricia Schofield, Christoph Muller, Ping-Tao Tseng, Pao-Yen Lin, André F. Carvalho, Marco Solmi. Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis. Journal of the American Geriatrics Society, 2017; DOI: 10.1111/jgs.14883

Cite This Page:

Wiley. "No benefit to aspirin for preserving cognitive function, review finds." ScienceDaily. ScienceDaily, 20 April 2017. <www.sciencedaily.com/releases/2017/04/170420090133.htm>.
Wiley. (2017, April 20). No benefit to aspirin for preserving cognitive function, review finds. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2017/04/170420090133.htm
Wiley. "No benefit to aspirin for preserving cognitive function, review finds." ScienceDaily. www.sciencedaily.com/releases/2017/04/170420090133.htm (accessed May 23, 2017).

RELATED STORIES